1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Positive CHMP Rec for Merck's Remicade – Zacks.com

January 23, 2012Immunosuppressive Drugsadmin

Positive CHMP Rec for Merck's Remicade
Zacks.com
The CHMP recommended the use of Remicade in pediatric patients who have not responded sufficiently to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are unable to opt for conventional therapy due to ...
Merck & Co gets positive CHMP opinion for Remicade in new indicationThe Pharma Letter

all 6 news articles »

Post navigation

← Allegheny General Hospital Heart, Liver Transplant Programs Rank Among … – PR Web (press release) Beyond the Abstract – Persistent overuse of radical nephrectomy in the elderly … – UroToday →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos